Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olympus: UGN-101 for Upper Urinary Tract Urothelial Carcinoma
NCT02793128Phase 3Completed
- Sponsor
- UroGen Pharma
- Start
- Apr 2017
- Primary completion
- Apr 2019
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of mitomycin c in upper tract urothelial carcinoma (UTUC), sponsored by UroGen Pharma. Started Apr 2017; status: completed.
02
Drugs
mitomycin c
03
Conditions
upper tract urothelial carcinoma (UTUC)
Beyond the preview
Go deeper on NCT02793128.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02793128.